PANews reported on November 21 that, according to Onchain Lens monitoring, a trader has made a floating profit of $19.51 million through his high-leverage short positions on the HyperLiquid platform. He further increased his short positions: ETH shorts increased from 259 to 1204.67, worth $3.23 million; SOL shorts increased from 438,868 to 462,374.2, worth $57.3 million. His cumulative profits have climbed from $18.9 million to $27.8 million.PANews reported on November 21 that, according to Onchain Lens monitoring, a trader has made a floating profit of $19.51 million through his high-leverage short positions on the HyperLiquid platform. He further increased his short positions: ETH shorts increased from 259 to 1204.67, worth $3.23 million; SOL shorts increased from 438,868 to 462,374.2, worth $57.3 million. His cumulative profits have climbed from $18.9 million to $27.8 million.

A trader has increased his short positions in ETH and SOL, bringing his total profits to $27.8 million.

2025/11/21 20:21

PANews reported on November 21 that, according to Onchain Lens monitoring, a trader has made a floating profit of $19.51 million through his high-leverage short positions on the HyperLiquid platform.

He further increased his short positions: ETH shorts increased from 259 to 1204.67, worth $3.23 million; SOL shorts increased from 438,868 to 462,374.2, worth $57.3 million. His cumulative profits have climbed from $18.9 million to $27.8 million.

Market Opportunity
Ethereum Logo
Ethereum Price(ETH)
$3,320
$3,320$3,320
-0.29%
USD
Ethereum (ETH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.